Abstract is: Lactulose is a non-absorbable sugar used in the treatment of constipation and hepatic encephalopathy. It is used by mouth for constipation and either by mouth or in the rectum for hepatic encephalopathy. It generally begins working after 8–12 hours, but may take up to 2 days to improve constipation. Common side effects include abdominal bloating and cramps. A potential exists for electrolyte problems as a result of the diarrhea it produces. No evidence of harm to the baby has been found when used during pregnancy. It is generally regarded as safe during breastfeeding. It is classified as an osmotic laxative. Lactulose was first made in 1929, and has been used medically since the 1950s. It is on the World Health Organization's List of Essential Medicines. It is available as a generic and brand-name product. Lactulose is made from the milk sugar lactose, which is composed of two simple sugars, galactose and glucose.
| P4250 | defined daily dose | 6.7 | |
| P527 | has part(s) | hydrogen | Q556 |
| oxygen | Q629 | ||
| carbon | Q623 | ||
| P366 | has use | medication | Q12140 |
| P2067 | mass | 342.116 | |
| P2175 | medical condition treated | hepatic encephalopathy | Q642548 |
| constipation | Q178436 | ||
| hepatic coma | Q18554341 | ||
| P3489 | pregnancy category | US pregnancy category B | Q28123616 |
| P3364 | stereoisomer of | maltulose | Q106054650 |
| P2868 | subject has role | essential medicine | Q35456 |
| gastrointestinal agent | Q50377202 | ||
| P2275 | World Health Organisation international non-proprietary name | lactulose |
| Q61979586 | A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation |
| Q113895937 | A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects |
| Q113912281 | A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix |
| Q63393381 | Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2 |
| Q113913121 | Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation |
| Q63062267 | Comparison of TCM and Laxatives for Adults With Chronic Constipation |
| Q113928555 | Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children |
| Q63393112 | Effect of Genetic Variation in Starch-digesting Enzymes on Digestibility and Glycemic Index of Cold and Hot Rice |
| Q61932344 | Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life |
| Q61938839 | Effects of Gum Chewing on Appetite and Digestion |
| Q113917428 | Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy |
| Q63062848 | Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy |
| Q113918279 | GI Effects of Iron in Healthy Volunteers |
| Q63573321 | Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea |
| Q113911470 | Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification |
| Q63571598 | Intestinal Permeability in Preterm Infants |
| Q113921967 | Lubiprostone for Functional Constipation in the Under 18 Years Patients |
| Q63341052 | Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies. |
| Q86244449 | Movicol in Childhood Constipation (ProMotion Study) (2000-10-31) |
| Q63404473 | Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis |
| Q63339279 | Pilot Study of the Effect of Lactulose on Post Caesarean Section Constipation |
| Q97045453 | Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial) |
| Q61934458 | RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial |
| Q62818407 | Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) |
| Q63321505 | S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE |
| Q61909226 | To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis. |
| Q61909101 | To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF). |
| Q63401191 | To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics. |
| Q50704728 | "If they can't tell the difference between duphalac and digoxin you've got patient safety issues". Nurse Lecturers' constructions of students' dyslexic identities in nurse education. |
| Q94208782 | 194 Lactulose and hydrogen-rich water protect against fusarium mycotoxin-induced intestinal injury in female piglets |
| Q35678957 | A 14-day elemental diet is highly effective in normalizing the lactulose breath test |
| Q58780885 | A Galacto-Oligosaccharides Preparation Derived From Lactulose Protects Against Colorectal Cancer Development in an Animal Model |
| Q59384767 | A Lactulose Bienzyme Biosensor Based on Self-Assembled Monolayer Modified Electrodes |
| Q88397413 | A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy |
| Q57826472 | A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy |
| Q67879935 | A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients |
| Q37649460 | A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test |
| Q33457676 | A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome |
| Q47209314 | A comparative study of the mouth to caecum transit time in children and adults using a weight adapted lactulose dose |
| Q55040187 | A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. |
| Q72590138 | A comparison of Agiolax and lactulose in elderly patients with chronic constipation |
| Q54261546 | A comparison of the effect of 9.5 gram/day resistant starch and lactulose on colon function. |
| Q104275452 | A comparison of the safety and efficacy of polyethylene glycol 4000 and lactulose for the treatment of constipation in pregnant women: a randomized controlled clinical study |
| Q48882051 | A controlled clinical trial of lactulose in hepatic encephalopathy |
| Q33441314 | A dietary fiber mixture versus lactulose in the treatment of childhood constipation: a double-blind randomized controlled trial |
| Q77635659 | A lactulose sensor based on coupled enzyme reactions with a ring electrode fabricated from tetrathiafulvalen-tetracyanoquinodimetane |
| Q24673627 | A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing |
| Q37993086 | A literature review of two laxatives: lactulose and polyethylene glycol |
| Q44974978 | A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy |
| Q53939038 | A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation. |
| Q60290574 | A new enzymatic spectrophotometric assay for the determination of lactulose in milk |
| Q84542513 | A pilot study on crystalline lactulose for colonoscopy bowel preparation |
| Q47624674 | A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction |
| Q57645017 | A possible case of minimal hepatic encephalopathy treated successfully with lactulose |
| Q33824656 | A randomised, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children |
| Q48655913 | A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy |
| Q51222196 | A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. |
| Q70787369 | A rapid gas-liquid chromatography method for the determination of lactulose and mannitol in urine: clinical application in studies of intestinal permeability |
| Q72613507 | A rapid method for the assay of lactulose |
| Q46868553 | A reference interval study of urinary lactulose excretion: a useful test of intestinal permeability in adults |
| Q70465942 | A simple enzymatic method for the assay of urinary lactulose |
| Q44590290 | A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients |
| Q92147760 | A study of the prebiotic effect of lactulose at low dosages in healthy Japanese women |
| Q43674298 | ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy |
| Q37822613 | ACP Journal Club. Review: Polyethylene glycol is more effective than lactulose for chronic constipation in children and adults |
| Q44503804 | Abdominal distension after colonic lactulose fermentation recorded by a new extensometer |
| Q69439350 | Absorption of Lactulose in Man |
| Q41439105 | Absorption of lactulose from mammalian gastrointestinal tract |
| Q56774700 | Acid production from lactulose by dental plaque bacteria |
| Q89254899 | Aetiological spectrum, clinical differentiation and efficacy of polyethylene glycol over lactulose in children with constipation: Experience of 316 cases |
| Q69619259 | Ammonia and glutamine metabolism of the intestine. The effect of lactulose and neomycin |
| Q71216106 | Ammonia production by intestinal bacteria: the effects of lactose, lactulose and glucose |
| Q50860492 | An Approach for Lactulose Production Using the CotX-Mediated Spore-Displayed β-Galactosidase as a Biocatalyst. |
| Q104108998 | An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia |
| Q48267520 | An efficient process for obtaining prebiotic oligosaccharides derived from lactulose using isomerized and purified whey permeate. |
| Q68029927 | An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults |
| Q46604042 | An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy |
| Q50794710 | Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy. |
| Q41622741 | Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model |
| Q70599312 | Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16 |
| Q43342388 | Application of Oral Lactulose in Combination With Polyethylene Glycol Electrolyte Powder for Colonoscopy Bowel Preparation in Patients With Constipation |
| Q43743325 | Assessment of gastrointestinal permeability by lactulose test in sheep after repeated indomethacin treatment. |
| Q73717646 | Assessment of protein quality of infant milk food formula supplemented with lactulose |
| Q35858688 | Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial |
| Q33465703 | Assessment of the impacts of traditional Persian medical schemes and recommendations on functional chronic constipation compared to a classic medicine lactulose, a randomized clinical trial |
| Q50085703 | Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients |
| Q28366938 | Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time |
| Q51636561 | Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests. |
| Q33458349 | Association between symptoms of irritable bowel syndrome and methane and hydrogen on lactulose breath test |
| Q70813852 | Automated anion-exchange chromatographic method for the quantitation of lactulose in physiological fluids and processed milks |
| Q68737441 | Automated enzymatic assays for the determination of intestinal permeability probes in urine. 1. Lactulose and lactose |
| Q33431832 | Basal fecal fermentation and with lactulose in patients with flatulence |
| Q85347592 | Batch and continuous synthesis of lactulose from whey lactose by immobilized β-galactosidase |
| Q45918321 | Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. |
| Q92400418 | Beyond Lactulose: Treatment Options for Hepatic Encephalopathy |
| Q95491844 | Beyond Lactulose: Treatment Options for Hepatic Encephalopathy |
| Q43281074 | Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy |
| Q53445762 | Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. |
| Q57634599 | Biocatalytic Approaches Using Lactulose: End Product Compared with Substrate |
| Q58797877 | Blood glucose response after oral intake of lactulose in healthy volunteers: A randomized, controlled, cross-over study |
| Q85519052 | Borate enhances the production of lactulose from lactose by cellobiose 2-epimerase from Caldicellulosiruptor saccharolyticus |
| Q48892613 | Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study |
| Q38952471 | Breath hydrogen concentrations after oral lactose and lactulose in tropical malabsorption and adult hypolactasia |
| Q45032657 | Breath hydrogen excretion or plasma acetate levels during the lactulose tolerance test? |
| Q34391507 | Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status |
| Q51608412 | Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis |
| Q44700987 | Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption |
| Q43328365 | Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose? |
| Q33449473 | Can partially hydrolyzed guar gum be an alternative to lactulose in treatment of childhood constipation? |
| Q43250316 | Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose |
| Q44249373 | Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability |
| Q70366958 | Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy |
| Q43338845 | Changes in intestinal transit time after proctocolectomy assessed by the lactulose breath test |
| Q69874575 | Changes in the bacterial population of the intestine following lactulose administration |
| Q67256006 | Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl) |
| Q43029113 | Characterisation of a novel cellobiose 2-epimerase from thermophilic Caldicellulosiruptor obsidiansis for lactulose production |
| Q62083585 | Characterization of galactooligosaccharides derived from lactulose |
| Q53447871 | Chemoprevention of colorectal tumors: role of lactulose and of other agents. |
| Q35218494 | Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. |
| Q72109575 | Cirrhosis, hyperammonemia and Lactulose |
| Q39674496 | Cleavage of lactulose by Bacillus megaterium |
| Q93018150 | Clinical benefit of oral lactulose for postoperative care of pateints with complicated appendicitis using propensity score matching analysis |
| Q37660968 | Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study |
| Q48577164 | Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis |
| Q73939817 | Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy |
| Q71905993 | Clinical studies with the laxative Duphalac |
| Q51503436 | Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome. |
| Q48159208 | Cochrane systematic review highlights the importance of lactulose in the management of hepatic encephalopathy. |
| Q46693619 | Colonic fermentation from lactulose inhibits lipolysis in overweight subjects |
| Q71885636 | Colonic transit times and the effect of lactulose or lactitol in hospitalized patients |
| Q60301622 | Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy |
| Q100631849 | Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure |
| Q35010368 | Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B. |
| Q34152148 | Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS |
| Q46093660 | Combined orocecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects orocecal transit, not small intestinal bacterial overgrowth in patients with irritable bowel syndrome |
| Q88362959 | Comment on: Treatment of Acute Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes |
| Q51867865 | Comparative effects of lactulose and magnesium sulfate on urea metabolism and nitrogen excretion in cirrhotic subjects. |
| Q96773771 | Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study |
| Q24548115 | Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy |
| Q48598965 | Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose |
| Q69765325 | Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy |
| Q70152864 | Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study |
| Q66847578 | Comparison between sucrose and lactulose in a suspended salivary system |
| Q64055170 | Comparison of Polyethylene Glycol versus Lactulose Oral Solution for Bowel Preparation prior to Colonoscopy |
| Q47649667 | Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy |
| Q35855681 | Comparison of a Chinese Herbal Medicine (CCH1) and Lactulose as First-Line Treatment of Constipation in Long-Term Care: A Randomized, Double-Blind, Double-Dummy, and Placebo-Controlled Trial |
| Q24670446 | Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation |
| Q84277926 | Comparison of abdominal bloating severity between Irritable Bowel Syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test |
| Q86602044 | Comparison of an enzymatic assay with liquid chromatography-pulsed amperometric detection for the determination of lactulose and mannitol in urine of healthy subjects and patients with active celiac disease |
| Q67542512 | Comparison of an in vitro faecal hydrogen test with the lactulose breath test: assessment of in vivo hydrogen-producing capability in Burmese village children |
| Q34475212 | Comparison of bran, ispaghula, and lactulose on colon function in diverticular disease |
| Q34486592 | Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate |
| Q46150586 | Comparison of inulin and lactulose as reference standards in the breath hydrogen test assessment of carbohydrate malabsorption in patients with chronic pancreatic exocrine insufficiency |
| Q83800501 | Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome |
| Q41667246 | Comparison of lactulose and inulin as reference standard for the study of resistant starch fermentation using hydrogen breath test. |
| Q34255207 | Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial |
| Q44012834 | Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children |
| Q35026388 | Comparison of preference and safety of powder and liquid lactulose in adult patients with chronic constipation |
| Q41867374 | Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats |
| Q43496339 | Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol |
| Q33628162 | Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study |
| Q73014209 | Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit |
| Q91833881 | Complex-oligosaccharide composed of galacto-oligosaccharide and lactulose ameliorates loperamide-induced constipation in rats |
| Q51865185 | Conservation of mannitol, lactulose, and raffinose by the human colon. |
| Q67585502 | Constipation in childhood: a controlled comparison between lactulose and standardized senna |
| Q71738593 | Constipation in long-stay elderly patients: its treatment and prevention by lactulose, poloxalkol-dihydroxyanthroquinolone and phosphate enemas |
| Q43285872 | Constipation in pregnant women - use of Duphalac |
| Q39553691 | Constipation in the elderly. II. Prevalence and causes of the use of laxatives and experiences with volume expanders and lactulose in nursing home patients |
| Q91306652 | Continuous enzymatic synthesis of lactulose in packed-bed reactor with immobilized Aspergillus oryzae β-galactosidase |
| Q43207024 | Continuous production of lactulose by immobilized thermostable beta-glycosidase from Pyrococcus furiosus |
| Q35196429 | Continuous synthesis of lactulose in an enzymatic membrane reactor reduces lactulose secondary hydrolysis |
| Q102069777 | Contribution to the Process Development for Lactulose Production through Complete Valorization of Whey Permeate by Using Electro-Activation Technology Versus a Chemical Isomerization Process |
| Q41031710 | Control of endotoxinemia in liver disease by lactulose and paromomycin |
| Q70199227 | Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis |
| Q40827469 | Controlled trial on the usefulness of low-dose lactulose in the treatment of digestive disturbances |
| Q89596811 | Correction: Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene |
| Q92722501 | Correlation between Lactulose and Furosine in UHT-Heated Milk |
| Q41816620 | Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction |
| Q50086100 | Corrigendum to "Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients" [J Food Drug Anal 24 (2016) 876-880]. |
| Q33449140 | Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose |
| Q94701918 | Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK |
| Q90040679 | Cross-over study in hyperammonemia patients for efficacy, safety, and acceptability of a new lactulose preparation (SK-1202) compared to approved drug |
| Q30909115 | Crystal structure and n.m.r. analysis of lactulose trihydrate |
| Q34155056 | Crystalline lactulose and oral preparations of micro-organisms for the treatment of chronic aspecific diarrhea in children. A controlled clinical study |
| Q50175851 | Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results |
| Q46636613 | Culture-proven small intestinal bacterial overgrowth as a cause of irritable bowel syndrome: response to lactulose but not broadspectrum antibiotics |
| Q45163600 | Deadaption and readaptation with lactose, but no cross-adaptation to lactulose: a case of occult colonic bacterial adaptation |
| Q34529459 | Delayed mouth-caecum transit of a lactulose labelled liquid test meal in patients with steatorrhoea caused by partially treated coeliac disease |
| Q36339442 | Design and application of a lactulose biosensor |
| Q46572204 | Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls |
| Q67351283 | Determination of Mannitol and Lactulose in Urine of Colorectal Cancer Patient by Ion-Exchange Chromatography |
| Q70769827 | Determination of boron impurities in syrups containing lactulose |
| Q69549809 | Determination of lactulose and soya oligosaccharides in infant formula milk feeds |
| Q69750677 | Determination of lactulose in lactulose syrup |
| Q67942657 | Determination of mannitol and lactulose in urine by capillary gas chromatography |
| Q35649153 | Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects. |
| Q52964083 | Development, optimization and validation of an HPLC-ELSD method for the analysis of enzymatically generated lactulose and saccharide by-products. |
| Q97587678 | Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates |
| Q46718728 | Diagnosis of small intestinal bacterial overgrowth in children: the use of lactulose in the breath hydrogen test as a screening test |
| Q35596086 | Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats |
| Q43784855 | Dietary lactulose decreases apparent nitrogen absorption and increases apparent calcium and magnesium absorption in healthy dogs |
| Q44034164 | Different therapeutic approaches for chronic diffuse liver lesions using ornicetil, lactulose, etimizol and corinfar |
| Q72590071 | Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis |
| Q90617047 | Differentiation of functional gastrointestinal disorders from healthy volunteers by lactulose hydrogen breath test and test meal |
| Q60489966 | Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test |
| Q44351749 | Dilemmas of clinical experimentation: use of lactulose in portocaval encephalopathy |
| Q44259783 | Diminished efficacy of colonic adaptation to lactulose occurs in patients with inflammatory bowel disease in remission |
| Q30469690 | Direct analysis of mannitol, lactulose and glucose in urine samples by high-performance anion-exchange chromatography with pulse amperometric detection. Clinical evaluation of intestinal permeability in human immunodeficiency virus infection |
| Q43779963 | Disturbance of liver functions and dysbiosis in patients with lipid distress syndrome and its treatment with lactulose preparation "Duphalac" (lactulose) |
| Q34778501 | Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile |
| Q46425077 | Does 'sugar' permeability reflect macromolecular absorption? A comparison of the gastro-intestinal uptake of lactulose and beta-lactoglobulin in the neonatal guinea pig. |
| Q41195510 | Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine |
| Q54528178 | Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt |
| Q69336005 | Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt |
| Q58108357 | Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome |
| Q37037795 | Double-blind controlled randomised study of lactulose and lignin hydrolysed combination in complex therapy of atopic dermatitis |
| Q43135485 | Double-blind prospective randomized study comparing polyethylene glycol to lactulose for bowel preparation in colonoscopy |
| Q33434211 | Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children |
| Q52039402 | Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy. |
| Q41761034 | Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats |
| Q43739663 | Duphalac in combination therapy of patients with hepatic cirrhosis |
| Q43871015 | Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. |
| Q49350073 | Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth |
| Q68081961 | Effect of Carbolevure on intestinal fermentation induced by the ingestion of lactulose |
| Q60199025 | Effect of Lactitol and Lactulose Administration on the Fecal Flora in Cirrhotic Patients |
| Q93232474 | Effect of Lyophilized, Encapsulated Lactobacillus fermentum and Lactulose Feeding on Growth Performance, Heavy Metals, and Trace Element Residues in Rainbow Trout (Oncorhynchus mykiss) Tissues |
| Q91889343 | Effect of Storage Temperature on Lactulose and 5-hydroxymethyl-furfural Formation in UHT Milk |
| Q70301448 | Effect of acetylsalicylic acid on symptoms and hydrogen excretion in the disaccharide tolerance test with lactose or lactulose |
| Q72712340 | Effect of acute lactulose administration on serum acetate levels in cirrhosis |
| Q44386476 | Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES). |
| Q34538983 | Effect of combined administration of bile duct decompression and lactulose in mechanical jaundice |
| Q35834282 | Effect of dietary lactulose supplementation on growth performance, nutrient digestibility, meat quality, relative organ weight, and excreta microflora in broilers |
| Q67510826 | Effect of feeding infant formula containing lactulose on intestinal flora in the infant |
| Q82212183 | Effect of fluid intake on the outcome of constipation in children: PEG 4000 versus lactulose |
| Q34071360 | Effect of four days of preoperative lactulose on posthaemorrhoidectomy pain: results of placebo controlled trial |
| Q57657944 | Effect of inclusion of lactulose and Lactobacillus plantarum on the intestinal environment and performance of piglets at weaning |
| Q43326826 | Effect of lactose, lactulose and bisacodyl on gastrointestinal transit studied by metal detector. |
| Q54611248 | Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. |
| Q41466129 | Effect of lactulose and fiber-rich diets on bile in relation to gallstone disease: an update |
| Q88165157 | Effect of lactulose intervention on gut microbiota and short chain fatty acid composition of C57BL/6J mice |
| Q39185191 | Effect of lactulose on ammonia production in a fecal incubation system |
| Q46584872 | Effect of lactulose on bacterial translocation and intestinal adaptation in a rat model of short bowel syndrome |
| Q54564700 | Effect of lactulose on bacterial translocation. |
| Q68964600 | Effect of lactulose on biliary lipid composition |
| Q46665667 | Effect of lactulose on biotransformation of isoflavone glycosides to aglycones in soymilk by lactobacilli |
| Q80277126 | Effect of lactulose on calcium and magnesium absorption: a study using stable isotopes in adult men |
| Q51577547 | Effect of lactulose on carbohydrate metabolism and diabetes mellitus. |
| Q34473821 | Effect of lactulose on cerebral metabolism in patients with chronic portosystemic encephalopathy |
| Q35064528 | Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model |
| Q42719993 | Effect of lactulose on growth performance and intestinal morphology of pre-ruminant calves using a milk replacer containing Enterococcus faecium |
| Q40350689 | Effect of lactulose on rabbits fed on a low residue diet |
| Q72998548 | Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficile |
| Q68583687 | Effect of lactulose on the metabolism of short-chain fatty acids |
| Q42479946 | Effect of lactulose supplementation on growth performance, intestinal histomorphology, cecal microbial population, and short-chain fatty acid composition of broiler chickens |
| Q39267011 | Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode |
| Q28361895 | Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis |
| Q34527975 | Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test |
| Q33296911 | Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study |
| Q89876095 | Effect of polyethylene glycol versus lactulose on abdominal pain in children occult constipation: a randomized controlled study |
| Q42560239 | Effect of preoperative lactulose on posthaemorrhoidectomy pain |
| Q43220595 | Effect of protein and lactulose on the production of gamma-aminobutyric acid by faecal Escherichia coli |
| Q90840945 | Effect of purification of galactooligosaccharides derived from lactulose with Saccharomyces cerevisiae on their capacity to bind immune cell receptor Dectin-2 |
| Q45169657 | Effect of rectal lactulose administration with oral therapy on time to recovery from hepatic encephalopathy: a randomized study |
| Q69062092 | Effect of the protein, citrate and phosphate content of milk on formation of lactulose during heat treatment |
| Q43308884 | Effectiveness of lactulose syrup after cardiac surgery. |
| Q70830583 | Effects of autohydrolyzed lignin and lactulose on gallbladder bile composition in hamsters |
| Q43547273 | Effects of cyclophosphamide and lactulose on the release of ammonia and medium-molecular-weight substances from the intestine into blood in rats. |
| Q42720098 | Effects of inulin and lactulose on the intestinal morphology of calves |
| Q93811964 | Effects of lactulose and Lactobacillus acidophilus on the fecal flora |
| Q44555650 | Effects of lactulose and lactitol on coliform bacteria and bacterial translocation in the caecum during 72-h starvation in rats |
| Q53447876 | Effects of lactulose and lactitol on colonic microflora and enzymatic activity. |
| Q41941926 | Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy |
| Q70265691 | Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects |
| Q41981421 | Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device |
| Q45250883 | Effects of lactulose and polyethylene glycol on colonic transit |
| Q54447129 | Effects of lactulose and silymarin on liver enzymes in cirrhotic rats. |
| Q44522066 | Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats. |
| Q41466142 | Effects of lactulose on nitrogen metabolism |
| Q64973852 | Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. |
| Q44208033 | Effects of lactulose on the intestinal microflora of periparturient sows and their piglets |
| Q47235231 | Effects of lactulose supplementation on performance, blood profiles, excreta microbial shedding of Lactobacillus and Escherichia coli, relative organ weight and excreta noxious gas contents in broilers |
| Q46577928 | Effects of lactulose supplementation on the growth of bifidobacteria and biotransformation of isoflavone glycosides to isoflavone aglycones in soymilk |
| Q44551514 | Effects of lactulose treatment on the course of subclinical hepatic encephalopathy |
| Q44323656 | Effects of melatonin and lactulose on the liver and kidneys in rats with obstructive jaundice |
| Q90976312 | Effects of sialylated lactulose on the mouse intestinal microbiome using Illumina high-throughput sequencing |
| Q39637656 | Effects of the prebiotics inulin and lactulose on intestinal immunology and hematology of preruminant calves. |
| Q46745530 | Effects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit |
| Q64885661 | Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study. |
| Q90418278 | Efficacy and safety of lactulose for the treatment of irritable bowel syndrome |
| Q38178702 | Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review |
| Q38286627 | Efficacy and tolerability of rifaximin in combination with lactulose in end-stage liver disease patients with MELD greater than 20: a single center experience |
| Q73009209 | Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy |
| Q38867092 | Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding |
| Q44056361 | Efficacy of lactulose plus 13C-acetate breath test in the diagnosis of gastrointestinal motility disorders |
| Q43409650 | Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis |
| Q43332613 | Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. |
| Q86168458 | Efficient lactulose production from cheese whey using sodium carbonate |
| Q50962687 | Efficient production of lactulose from whey powder by cellobiose 2-epimerase in an enzymatic membrane reactor. |
| Q62083613 | Egg shell as catalyst of lactose isomerisation to lactulose |
| Q42094687 | Emergency treatment of portal-systemic encephalopathy with lactulose enemas. A controlled study |
| Q89184509 | Enhancement of isomerization activity and lactulose production of cellobiose 2-epimerase from Caldicellulosiruptor saccharolyticus |
| Q52073272 | Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. |
| Q90125226 | Enzymatic generation of lactulose in sweet and acid whey: Optimization of feed composition and structural elucidation of 1-lactulose |
| Q38115162 | Enzymatic production of lactulose and 1-lactulose: current state and perspectives |
| Q43025319 | Enzymatic production of lactulose and epilactose in milk |
| Q42640490 | Enzymatic synthesis and identification of two trisaccharides produced from lactulose by transgalactosylation. |
| Q28370851 | Epidemiology of altered intestinal permeability to lactulose and mannitol in Guatemalan infants |
| Q43341347 | Estimation of intestinal trehalase activity from a laxative threshold of trehalose and lactulose on healthy female subjects |
| Q49679832 | Evaluation of Anti-Wrinkle Effects of DuOligo, Composed of Lactulose and Galactooligosaccharides |
| Q58030981 | Evaluation of Oligosaccharide Synthesis from Lactose and Lactulose Using β-Galactosidases from Kluyveromyces Isolated from Artisanal Cheeses |
| Q52984024 | Evaluation of computed tomographic enterography with an orally administered lactulose solution in clinically normal dogs. |
| Q44096046 | Evaluation of hydrogen excretion after lactulose administration as a screening test for causes of irritable bowel syndrome |
| Q34408142 | Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A |
| Q91844696 | Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: A focus on methane |
| Q70359076 | Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man |
| Q73046170 | Evaluation of oro-coecal transit time: a comparison of the lactose-[13C, 15N]ureide 13CO2- and the lactulose H2-breath test in humans |
| Q38319952 | Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study. |
| Q39488616 | Evaluation of the effect of rifaximin in colon diverticular disease by means of lactulose hydrogen breath test |
| Q30885569 | Evaluation of the inclusion of a mixture of organic acids or lactulose into the feed of pigs experimentally challenged with Salmonella Typhimurium |
| Q70780988 | Excess pulmonary excretion of hydrogen in response to lactulose |
| Q69637612 | Experimental and clinical study of lactulose in obstructive jaundice |
| Q54270771 | Expression and characterization of two β-galactosidases from Klebsiella pneumoniae 285 in Escherichia coli and their application in the enzymatic synthesis of lactulose and 1-lactulose. |
| Q102370820 | External use of Mirabilite combined with Lactulose improves postoperative gastrointestinal mobility among older patients undergoing abdominal surgery |
| Q43250020 | Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics |
| Q46253420 | Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration. |
| Q67964480 | Faecal steroids and colorectal cancer: the effect of lactulose on faecal bacterial metabolism in a continuous culture model of the large intestine |
| Q28842810 | Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties |
| Q51017097 | Fed-batch operation for the synthesis of lactulose with β-galactosidase of Aspergillus oryzae. |
| Q43706559 | Formation kinetics of hydroxymethylfurfural, lactulose and furosine in milk heated under isothermal and non-isothermal conditions. |
| Q59087731 | Formation of Lactulose and Tagatose from Lactose in strongly heated Milk |
| Q77415763 | Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters |
| Q87514261 | Galacto-oligosaccharides and lactulose as protectants against desiccation of Lactobacillus delbrueckii subsp. bulcaricus |
| Q34820621 | Galacto-oligosaccharides derived from lactulose exert a selective stimulation on the growth of Bifidobacterium animalis in the large intestine of growing rats |
| Q59280921 | Galactooligosaccharides derived from lactose and lactulose: Influence of structure on Lactobacillus, Streptococcus and Bifidobacterium growth |
| Q71686243 | Galactosamine hepatitis, endotoxemia, and lactulose |
| Q43108371 | Gastric emptying and orocaecal transit time of meals containing lactulose or inulin in men. |
| Q45028942 | Gastric emptying of maltose, sucrose, lactose and lactulose in rats with ontogenic lactase deficiency |
| Q74256879 | Gastrointestinal complications of dermatomal herpes zoster successfully treated with famciclovir and lactulose |
| Q71106479 | Gut permeability to human alpha-lactalbumin, beta-lactoglobulin, mannitol, and lactulose in celiac disease |
| Q46160482 | Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects |
| Q56485422 | Heat-treated milk differentiation by a sensitive lactulose assay |
| Q39409390 | Helicobacter pylori infection is associated with high methane production during lactulose breath test |
| Q48712540 | Hepatic encephalopathy evaluated by automatic period analysis of the electroencephalogram during lactulose treatment. |
| Q87427546 | Heterofunctional hydrophilic-hydrophobic porous silica as support for multipoint covalent immobilization of lipases: application to lactulose palmitate synthesis |
| Q43874779 | Home lactulose enema: prevention of hepatic encephalopathy at home |
| Q33436461 | Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy |
| Q70650642 | Human intestinal methanogens and lactulose administration |
| Q69571648 | Hydrogen excretion after ingestion of five different sugar alcohols and lactulose |
| Q77734191 | Hydrogen production in dogs adapts to addition of lactulose and to a meat and rice diet |
| Q55515018 | Hydrogen-Rich Water and Lactulose Protect Against Growth Suppression and Oxidative Stress in Female Piglets Fed Fusarium Toxins Contaminated Diets. |
| Q89614388 | Hydrolysis and transgalactosylation catalysed by β-galactosidase from brush border membrane vesicles isolated from pig small intestine: A study using lactulose and its mixtures with lactose or galactose as substrates |
| Q66943461 | Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment |
| Q67582800 | Hypernatremia after the administration of lactulose |
| Q71669819 | Hypernatremia and lactulose therapy |
| Q67543143 | Hypocholesterolemic effect of lactulose in man: a preliminary report |
| Q95364173 | I recently had a lactose breath test to check for lactose intolerance. I'm not lactose intolerant, but now my doctor has ordered a lactulose breath test. Why do I need two tests? |
| Q44781590 | IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen |
| Q91136997 | Idiopathic pneumatosis intestinalis secondary to lactulose use in patients with cirrhosis |
| Q72749360 | Ileal pH and apparent absorption of magnesium in rats fed on diets containing either lactose or lactulose |
| Q70514315 | Ileus-like symptoms following lactulose |
| Q102216831 | Immobilization of Aspergillus oryzae β-galactosidase in cation functionalized agarose matrix and its application in the synthesis of lactulose |
| Q90921975 | Impact of Amorphization Methods on the Physicochemical Properties of Amorphous Lactulose |
| Q90975677 | Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO |
| Q87550634 | Impact of high-intensity ultrasound on the formation of lactulose and Maillard reaction glycoconjugates |
| Q86971506 | Improvement of efficiency in the enzymatic synthesis of lactulose palmitate |
| Q91060483 | Improvements in the production of Aspergillus oryzae β-galactosidase crosslinked aggregates and their use in repeated-batch synthesis of lactulose |
| Q37659678 | Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene |
| Q73327884 | In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters |
| Q46822301 | In vitro fermentation of lactulose by human gut bacteria |
| Q71212096 | Incidence of endotoxemia in pigs with ischemic hepatic necrosis treated by hemodialysis. Prevention of endotoxemia with lactulose |
| Q69602918 | Increased concentrations of liver cholesterol in rats fed lactulose |
| Q73377053 | Increased lactulose/rhamnose ratio during fluid load is caused by increased urinary lactulose excretion |
| Q51632861 | Increased superior mesenteric artery blood flow after glucose but not lactulose ingestion. |
| Q42125724 | Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive effects of dietary lactulose and calcium |
| Q43319878 | Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial |
| Q33901797 | Infant Nutritional Status, Feeding Practices, Enteropathogen Exposure, Socioeconomic Status, and Illness Are Associated with Gut Barrier Function As Assessed by the Lactulose Mannitol Test in the MAL-ED Birth Cohort |
| Q52275335 | Influence of alcohol on gastrointestinal motility: lactulose breath hydrogen testing in orocecal transit time in chronic alcoholics, social drinkers and teetotaler subjects. |
| Q34531455 | Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study) |
| Q50252224 | Influence of lactulose on interventional therapy for HCC patients with hepatocirrhosis and hypersplenism |
| Q79578879 | Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects |
| Q35593417 | Influences of operating conditions on continuous lactulose synthesis in an enzymatic membrane reactor system: A basis prior to long-term operation. |
| Q40322171 | Inhibition of bacteria by lactulose preparations. |
| Q53523730 | Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of two different age groups. |
| Q69388596 | Interactions of lactulose and neomycin |
| Q38780447 | Interpreting the Lactulose Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth |
| Q34391744 | Interval sampling of end-expiratory hydrogen (H2) concentrations to quantify carbohydrate malabsorption by means of lactulose standards |
| Q55515198 | Intestinal Microbiota Ecological Response to Oral Administrations of Hydrogen-Rich Water and Lactulose in Female Piglets Fed a Fusarium Toxin-Contaminated Diet. |
| Q57651397 | Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose |
| Q54464916 | Intestinal ammoniogenesis in normal rats. Comparative study of the action of antibiotics and lactulose |
| Q35157486 | Intestinal anti-inflammatory effects of oligosaccharides derived from lactulose in the trinitrobenzenesulfonic acid model of rat colitis. |
| Q72663595 | Intestinal calcium absorption in rats is stimulated by dietary lactulose and other resistant sugars |
| Q34131240 | Intestinal effects of mannanoligosaccharides, transgalactooligosaccharides, lactose and lactulose in dogs |
| Q47720376 | Intestinal fructose malabsorption is associated with increased lactulose fermentation in the intestinal lumen |
| Q33437461 | Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge |
| Q90473206 | Intestinal microbiome analysis demonstrates azithromycin post-treatment effects improve when combined with lactulose |
| Q51048563 | Intestinal permeability induced by lipopolysaccharide and measured by lactulose, rhamnose and mannitol sugars in chickens. |
| Q43773013 | Intestinal permeability testing using lactulose and rhamnose: a comparison between clinically normal cats and dogs and between dogs of different breeds |
| Q44964748 | Intestinal permeability to lactulose and mannitol in growing rats with iron-deficiency anemia |
| Q44270655 | Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele |
| Q45184727 | Investigation on the precaecal and faecal digestibility of lactulose and inulin and their influence on nutrient digestibility and microbial characteristics |
| Q42132744 | Is Hydrogen Breath Test with Lactulose Feasible for Measuring Gastrocecal Transit in Critically Ill Children? Pilot Study about Modification of the Technique. |
| Q50210136 | Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy? |
| Q89657080 | Kinetic study on the digestibility of lactose and lactulose using small intestinal glycosidases |
| Q44344322 | Kinetics of hydroxymethylfurfural, lactulose and furosine formation in milk with different fat content |
| Q33432461 | L-Rhamnose increases serum propionate after long-term supplementation, but lactulose does not raise serum acetate |
| Q51494335 | L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. |
| Q78358713 | LACTULOSE IN MODIFIED MILK PRODUCTS FOR INFANT NUTRITION |
| Q33466486 | Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study |
| Q33454293 | Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose |
| Q37867650 | Lactitol or lactulose in the treatment of chronic constipation: result of a systematic. |
| Q28318920 | Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis |
| Q61577524 | Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE) |
| Q33471561 | Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study |
| Q45019764 | Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial |
| Q70221905 | Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy |
| Q69905329 | Lactitol, lactulose, and blood ammonia |
| Q69909422 | Lactitol, lactulose, and blood ammonia |
| Q62056607 | Lactosamine from lactulose via the Heyns rearrangement: a practical protocol |
| Q88084717 | Lactose electroisomerization into lactulose: effect of the electrode material, active membrane surface area-to-electrode surface area ratio, and interelectrode-membrane distance |
| Q72126189 | Lactulose (Chronulac) for constipation |
| Q67860984 | Lactulose (cephulac) in portosystemic encephalopathy |
| Q48052838 | Lactulose Breath Test Gas Production in Childhood IBS Is Associated With Intestinal Transit and Bowel Movement Frequency. |
| Q63199359 | Lactulose Breath Test to Assess Oro-cecal Transit Delay and Estimate Esophageal Dysmotility in Scleroderma Patients |
| Q92675047 | Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass |
| Q91117798 | Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea |
| Q35817564 | Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome |
| Q36082987 | Lactulose Differently Modulates the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice |
| Q44616982 | Lactulose Enemas |
| Q36747480 | Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender |
| Q40356862 | Lactulose Is Associated With Decreased Risk of Clostridium difficile Infection in Decompensated Cirrhosis |
| Q91248073 | Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review |
| Q44594261 | Lactulose Reduces Intracolonic Acetaldehyde Concentration and Ethanol Elimination Rate in Rats |
| Q96136886 | Lactulose Suppresses Osteoclastogenesis and Ameliorates Estrogen Deficiency-Induced Bone Loss in Mice |
| Q33471970 | Lactulose Syrup Assessed in a Double-Blind Study of Elderly Constipated Patients |
| Q39073380 | Lactulose Therapy in Shigella Carrier State and Acute Dysentery |
| Q48858007 | Lactulose Treatment of Hepatic Encephalopathy in Outpatients |
| Q84081533 | Lactulose a day keeps encephalopathy at bay |
| Q86787688 | Lactulose accelerates liver regeneration in rats by inducing hydrogen |
| Q45172904 | Lactulose ameliorates cerebral ischemia-reperfusion injury in rats by inducing hydrogen by activating Nrf2 expression |
| Q34057157 | Lactulose and Lactobacillus plantarum, a potential complementary synbiotic to control postweaning colibacillosis in piglets |
| Q98734230 | Lactulose and Melibiose Attenuate MPTP-Induced Parkinson's Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy |
| Q95323070 | Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability |
| Q69909487 | Lactulose and ammonia |
| Q41168195 | Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora |
| Q72810261 | Lactulose and mannitol as probe markers for in vivo assessment of passive intestinal permeability in healthy cats |
| Q46985830 | Lactulose and mannitol intestinal permeability detected by capillary electrophoresis |
| Q77688964 | Lactulose and neomycin attenuate leukocyte-endothelial cell adhesion in an animal model of inflammatory bowel disease |
| Q72544764 | Lactulose and other non-absorbable sugars in infant milk feeds |
| Q41466160 | Lactulose and renal failure |
| Q69804346 | Lactulose and severe lactic acidosis |
| Q57436121 | Lactulose as a marker of intestinal barrier function in pigs after weaning1 |
| Q89059995 | Lactulose as a novel template for anticancer drug development targeting galectins |
| Q69374694 | Lactulose as an anti-endotoxin in liver transplantation |
| Q71884752 | Lactulose as an antiendotoxin in experimental colitis |
| Q52650539 | Lactulose attenuates METH-induced neurotoxicity by alleviating the impaired autophagy, stabilizing the perturbed antioxidant system and suppressing apoptosis in rat striatum. |
| Q82588921 | Lactulose biosynthesis by β-galactosidase from a newly isolated Arthrobacter sp |
| Q46944578 | Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection |
| Q46315990 | Lactulose breath testing and irritable bowel syndrome |
| Q46678855 | Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls |
| Q44729241 | Lactulose breath testing, bacterial overgrowth, and IBS: just a lot of hot air? |
| Q47850724 | Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats |
| Q88360506 | Lactulose determination in UHT milk by CZE-UV with indirect detection |
| Q68257405 | Lactulose detoxifies in vitro short-chain fatty acid production in colonic contents induced by blood: implications for hepatic coma |
| Q90134544 | Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs |
| Q69468429 | Lactulose enemas |
| Q49997865 | Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm? |
| Q36222808 | Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy. |
| Q42477659 | Lactulose feeding in piglets: a model for persistent diarrhea and colitis induced by severe sugar malabsorption |
| Q35929321 | Lactulose feeding lowers cecal densities of clostridia in piglets |
| Q66903253 | Lactulose for hepatic encephalopathy |
| Q36020921 | Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction |
| Q85260876 | Lactulose for reduction of nitrogen products in patients with chronic kidney disease |
| Q61454255 | Lactulose for the treatment of Chinese children with chronic constipation: A randomized controlled trial |
| Q44898117 | Lactulose hydrogen and [14C]xylose breath tests in patients with ileoanal anastomosis |
| Q51432735 | Lactulose hydrogen breath test and functional symptoms in pediatric patients. |
| Q72048477 | Lactulose hydrogen breath test in orocecal transit assessment. Critical evaluation by means of scintigraphic method |
| Q45130807 | Lactulose hydrogen breath test in the diagnosis of bacterial overgrowth |
| Q92861868 | Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial |
| Q34576485 | Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy |
| Q73094796 | Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy |
| Q67021644 | Lactulose in baby milks |
| Q67574282 | Lactulose in baby milks causing diarrhoea simulating lactose intolerance |
| Q41092752 | Lactulose in clinical use. |
| Q83201115 | Lactulose in fat-free milk, rather than increased ghrelin and motilin level, might help for solving constipation: author update |
| Q69931058 | Lactulose in hepatic encephalopathy |
| Q71623108 | Lactulose in liver failure |
| Q35466505 | Lactulose in the management of constipation: a current review |
| Q43983607 | Lactulose in the prevention of recurrent urinary tract infection. |
| Q69647717 | Lactulose in the therapy of porto-systemic encephalopathy |
| Q48822132 | Lactulose in the treatment of acute and chronic hepatic encephalopathy |
| Q47958015 | Lactulose in the treatment of acute hepatic encephalopathy |
| Q72603669 | Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases |
| Q47792483 | Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial |
| Q39183199 | Lactulose in the treatment of hepatic (pre)coma |
| Q84600560 | Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality |
| Q70705269 | Lactulose in the treatment of portacaval encephalopathy |
| Q48925251 | Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium. |
| Q68478690 | Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet |
| Q44347870 | Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis |
| Q69588435 | Lactulose in trimethylaminuria, the fish-odour syndrome |
| Q67055140 | Lactulose in vincristine-induced constipation |
| Q27312447 | Lactulose increases equol production and improves liver antioxidant status in barrows treated with Daidzein |
| Q104739090 | Lactulose ingestion causes an increase in the abundance of gut-resident bifidobacteria in Japanese women: a randomised, double-blind, placebo-controlled crossover trial |
| Q77734187 | Lactulose ingestion has No effect on plasma acetate in dogs studied with [1-13C] acetate |
| Q33431282 | Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. |
| Q28334317 | Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study |
| Q30461931 | Lactulose interferes in the alkaline picrate assay for creatinine |
| Q86367000 | Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial |
| Q85828768 | Lactulose leaves the leaky gut |
| Q51679154 | Lactulose lowers arterial ammonia in hepatic failure |
| Q28362351 | Lactulose may help prevent urinary tract infections |
| Q104472611 | Lactulose may reduce Clostridium difficile-related diarrhea among patients receiving antibiotics |
| Q46018290 | Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. |
| Q70877027 | Lactulose or lactose in hepatic encephalopathy? |
| Q72483767 | Lactulose or paromomycin do not affect ammonia generation in the isolated perfused rat small intestine |
| Q43351259 | Lactulose oral solution for the treatment of postpartum constipation |
| Q40487967 | Lactulose production by a thermostable glycoside hydrolase from the hyperthermophilic archaeon Caldivirga maquilingensis IC-167. |
| Q44691863 | Lactulose production by beta-galactosidase in permeabilized cells of Kluyveromyces lactis |
| Q51625483 | Lactulose production from cheese whey using recyclable catalyst ammonium carbonate. |
| Q48799041 | Lactulose production from efficient isomerization of lactose catalyzed by recyclable sodium aluminate |
| Q82709735 | Lactulose production from lactose as a single substrate by a thermostable cellobiose 2-epimerase from Caldicellulosiruptor saccharolyticus |
| Q57220800 | Lactulose production from milk concentration permeate using calcium carbonate-based catalysts |
| Q35062183 | Lactulose promotes equol production and changes the microbial community during in vitro fermentation of daidzein by fecal inocula of sows |
| Q87843650 | Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy |
| Q77995359 | Lactulose stimulates calcium absorption in postmenopausal women |
| Q90996394 | Lactulose synergizes with CpG-ODN to modulate epithelial and immune cells cross talk |
| Q70632683 | Lactulose therapy in chronic renal failure |
| Q69365940 | Lactulose therapy of periodontal diseases |
| Q71470566 | Lactulose therapy of the hepatoportal Encephalopathy |
| Q64117086 | Lactulose to the Rescue: A Case of Toxic Hepatic Encephalopathy Caused by Portosystemic Shunting and Epistaxis in a Patient with Hereditary Hemorrhagic Telangiectasia |
| Q81319593 | Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life |
| Q70463521 | Lactulose treatment in three patients with chronic portal-systemic encephalopathy |
| Q48919350 | Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study |
| Q48953086 | Lactulose treatment of hepatic encephalopathy: effects on carbohydrate metabolism and colonic hydrogen ion concentration |
| Q42904596 | Lactulose use in bowel preparation before pediatric colonoscopy |
| Q24236813 | Lactulose versus Polyethylene Glycol for Chronic Constipation |
| Q24242671 | Lactulose versus Polyethylene Glycol for Chronic Constipation |
| Q92433081 | Lactulose versus polyethylene glycol for disimpaction therapy in constipated children, a randomized controlled study |
| Q87237494 | Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy |
| Q95370877 | Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy |
| Q87237498 | Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply |
| Q38423365 | Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial |
| Q73781135 | Lactulose vs sorbitol for treatment of obstipation in hospice programs |
| Q70288908 | Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability |
| Q41494458 | Lactulose, disaccharides and colonic flora. Clinical consequences |
| Q40913091 | Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection |
| Q38070363 | Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? |
| Q91654309 | Lactulose: A Model System to Investigate Solid State Amorphization Induced by Milling |
| Q47885367 | Lactulose: A Simple Sugar in a Complex Encephalopathy |
| Q39185197 | Lactulose: A drug in search of a modus operandi |
| Q94493622 | Lactulose: Mannitol Test as an Indicator of a Potential Modifier of the Effect of Specialized Nutritious Foods in the Treatment of Moderate Acute Malnutrition in Sierra Leone (P10-122-19) |
| Q92600785 | Lactulose: Patient- and dose-dependent prebiotic properties in humans |
| Q71953140 | Lactulose: a crucial element in treating hepatic encephalopathy |
| Q70107569 | Lactulose: a gas-liquid chromatography method of determination and evaluation of its use to assess intestinal mucosal damage |
| Q39920415 | Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy |
| Q41840451 | Lactulose: an effective preventive and therapeutic option for ischemic stroke by production of hydrogen |
| Q71052835 | Lactulose: an ideal laxative for children |
| Q82239371 | Lactulose: an indirect antioxidant ameliorating inflammatory bowel disease by increasing hydrogen production |
| Q48720872 | Lactulose: comments on mechanism of action and current status |
| Q84902523 | Lactulose: how many ways can one drug be prescribed? |
| Q30409601 | Lactulose: mannitol diagnostic test by HPLC and LC-MSMS platforms: considerations for field studies of intestinal barrier function and environmental enteropathy |
| Q68247807 | Lactulose: pharmacodynamic evaluation |
| Q37920381 | Lactulose: production, purification and potential applications |
| Q44543465 | Lactulose: toxicological evaluation |
| Q43352702 | Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial |
| Q87578649 | Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy |
| Q87578651 | Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy--authors' reply |
| Q93074861 | Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy |
| Q52014877 | Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. |
| Q44530370 | Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy |
| Q64890901 | Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence. |
| Q43144206 | Low serum levels of short-chain fatty acids after lactulose ingestion may indicate impaired colonic fermentation in patients with irritable bowel syndrome |
| Q46863102 | Low-dose lactulose produces a tonic contraction in the human colon. |
| Q44259746 | Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth |
| Q41987205 | Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care |
| Q51595664 | Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity. |
| Q59137457 | METH-Induced Neurotoxicity Is Alleviated by Lactulose Pretreatment Through Suppressing Oxidative Stress and Neuroinflammation in Rat Striatum |
| Q54343620 | MR enterography with oral contrast agent composed of methylcellulose, low-dose barium sulfate, sorbitol, and lactulose: assessment of diagnostic performance, reliability, image quality, and patient tolerance. |
| Q51796902 | Maillard conjugation of lactulose with potentially bioactive peptides. |
| Q72155656 | Marked deterioration in glycemic control with change in brand of lactulose syrup |
| Q51628199 | Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium cromoglycate. |
| Q92498308 | Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS |
| Q28377346 | Measurement of intestinal permeability using mannitol and lactulose in children with diarrheal diseases |
| Q28370712 | Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease |
| Q46306562 | Measurement of the orocaecal transit time after an oral lactulose load--does the fasting breath hydrogen concentration affect the feasibility of the test? |
| Q44924808 | Megacolon during treatment with lactulose |
| Q35802519 | Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration |
| Q44367935 | Methane production during lactulose breath test is associated with gastrointestinal disease presentation |
| Q73191367 | Method development for the quantitative determination of lactulose in heat-treated milks by HPAEC with pulsed amperometric detection |
| Q63968586 | Microbiota stability in healthy individuals after single-dose lactulose challenge - a randomized controlled study |
| Q57788665 | Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study |
| Q51540254 | Microwave-assisted isomerisation of lactose to lactulose and Maillard conjugation of lactulose and lactose with whey proteins and peptides. |
| Q56485420 | Milk lactose and lactulose determination by the differential pH technique |
| Q92504912 | Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal |
| Q64997016 | Modern approach for determination of lactulose, mannitol and sucrose in human urine using HPLC-MS/MS for the studies of intestinal and upper digestive tract permeability. |
| Q104455608 | Modulation of gut microbiota and intestinal metabolites by lactulose improves loperamide-induced constipation in mice |
| Q63391480 | Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone |
| Q35023584 | Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii |
| Q91225634 | Morphological and Structural Properties of Amorphous Lactulose Studied by Scanning Electron Microscopy, Polarized Neutron Scattering, and Molecular Dynamics Simulations |
| Q64239814 | Morphological and molecular response of small intestine to lactulose and hydrogen-rich water in female piglets fed mycotoxins contaminated diet |
| Q43010311 | Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy. |
| Q40918214 | Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial |
| Q69910811 | New mode of action for lactulose |
| Q72867141 | New reactions of dextransucrase: α-d-glucosyl transfers to and from the anomeric sites of lactulose and fructose |
| Q33437214 | Nightly high dose lactulose infusion could be a cost-effective treatment for hepatic encephalopathy, renal insufficiency and heart failure |
| Q44900141 | Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin. |
| Q24185782 | Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis |
| Q24185895 | Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis |
| Q61687720 | Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome a double-blind, randomized, placebo-controlled study |
| Q44318836 | Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study |
| Q38841972 | Novel Lactulose and Melibiose Targeting Autophagy to Reduce PolyQ Aggregation in Cell Models of Spinocerebellar Ataxia 3. |
| Q44675268 | Nutritional status and breath hydrogen test with lactose and lactulose in Terena Indian children |
| Q44675263 | Nutritional status and breath hydrogen test with lactose and lactulose in children |
| Q36412162 | Observations on the curative effect of lactulose for postpartum constipation based on a large sample study |
| Q72213370 | On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats |
| Q86403602 | Optimisation of synthesis of oligosaccharides derived from lactulose (fructosyl-galacto-oligosaccharides) with β-galactosidases of different origin |
| Q53343940 | Optimization of lactulose synthesis from whey lactose by immobilized β-galactosidase and glucose isomerase. |
| Q46576255 | Oral administration of lactulose: a novel therapy for acute carbon monoxide poisoning via increasing intestinal hydrogen production |
| Q46052385 | Oral chenodeoxycholic acid increases small intestinal permeability to lactulose in humans. |
| Q39939518 | Organization of nocturnal sleep in patients with liver cirrhosis: changes before and after treatment with levodopa and lactulose |
| Q73736472 | Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial |
| Q90475433 | Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts |
| Q92678748 | Outcomes of lactulose plus branched-chain amino acid infusion and lactulose alone for hepatic encephalopathy: A retrospective cohort study using a national inpatient database |
| Q35826009 | Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon |
| Q24685783 | PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial |
| Q58089305 | PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized Study |
| Q28337550 | Pancreatic islet cell surface glycoproteins containing Gal beta 1-4GlcNAc-R identified by a cytotoxic monoclonal autoantibody |
| Q89070664 | Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy Trials |
| Q46772457 | Peroral CT enterography with lactulose solution: preliminary observations |
| Q64984380 | Pharmacoeconomic Impact of Low-Dose Macrogol 3350 plus Electrolytes Compared with Lactulose in the Management of Chronic Idiopathic Constipation among Ambulant Patients in Belgium. |
| Q38293783 | Pharmacological inhibition of galectin-1 by lactulose alleviates weight gain in diet-induced obese rats |
| Q90959668 | Phenylboronic Acid Functionalized Adsorbents for Selective and Reversible Adsorption of Lactulose from Syrup Mixtures |
| Q42529006 | Physical exercise and intermittent administration of lactulose may improve autism symptoms through hydrogen production |
| Q44845678 | Physiological effects of lactulose and inulin in the caecum of rats |
| Q51792651 | Pneumatosis cystoides intestinalis following lactulose and steroid treatment in a liver transplant patient with an intermittently enlarged scrotum. |
| Q37641048 | Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial |
| Q92129306 | Polyethylene Glycol vs. Lactulose in Infants and Children with Functional Constipation: Evidence-Based Medicine Viewpoint |
| Q92129312 | Polyethylene Glycol vs. Lactulose in Infants and Children with Functional Constipation: Pediatric Gastroenterologist's Viewpoint |
| Q83149183 | Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial |
| Q39268985 | Polyethylene glycol more effective than lactulose for relief of chronic constipation |
| Q41404397 | Porcine intestinal ammonia liberation. Influence of food intake, lactulose and neomycin treatment |
| Q34396164 | Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery |
| Q71061954 | Portal systemic encephalopathy--should lactulose and neomycin be used together |
| Q70613068 | Portal systemic encephalopathy-sorbitol--a potential replacement for lactulose |
| Q44618518 | Possible interesting dietetic effects of lactulose as a feed additive in pig feed |
| Q43028034 | Prebiotic effect of lactulose in preterm infants. |
| Q92311428 | Prebiotic effect of two grams of lactulose in healthy Japanese women: a randomised, double-blind, placebo-controlled crossover trial |
| Q96645463 | Prebiotic galactooligosaccharides production from lactose and lactulose by Lactobacillus delbrueckii subsp. bulgaricus CRL450 |
| Q45953153 | Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. |
| Q43222247 | Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy |
| Q69397780 | Preliminary study of the use of lactulose (1,4-beta-galactoside-fructose) in the long-term treatment of portal systemic encephalopathy |
| Q52585759 | Preparation of High-purity Lactulose through Efficient Recycle of Catalyst Sodium Aluminate and Nanofiltration: A Pilot-scale Purification. |
| Q51598519 | Prevalence and consistency of low breath H2 excretion following lactulose ingestion. Possible implications for the clinical use of the H2 breath test. |
| Q45285907 | Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis |
| Q72908722 | Prevention of cholesterol gallstones by lignin and lactulose in the hamster |
| Q104609738 | Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo contro |
| Q70153882 | Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a multicentre study of bile salts and lactulose |
| Q84164852 | Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose |
| Q42535168 | Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats. |
| Q41839416 | Probiotics and antibiotic associated diarrhoea. Lactulose is effective |
| Q85582404 | Production of 1-lactulose and lactulose using commercial β-galactosidase from Kluyveromyces lactis in the presence of fructose |
| Q58030967 | Production of lactulose oligosaccharides by isomerisation of transgalactosylated cheese whey permeate obtained by β-galactosidases from dairy Kluyveromyces |
| Q52229929 | Production rate of acetate during colonic fermentation of lactulose: a stable-isotope study in humans. |
| Q34996031 | Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose |
| Q47561074 | Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota. |
| Q82724683 | Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose |
| Q83988811 | Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation |
| Q44841392 | Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. |
| Q45104385 | Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats |
| Q50136217 | Protective effects of dietary lactulose and calcium phosphate against Salmonella infection |
| Q58040763 | Protective effects of prebiotics inulin and lactulose from cytotoxicity and genotoxicity in human colon adenocarcinoma cells |
| Q53466356 | Protective role of lactulose in intestinal carcinogenesis. |
| Q48358873 | Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy. |
| Q43260317 | Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. |
| Q71202583 | Pulmonary hydrogen and methane and plasma ammonia after the administration of lactulose or sorbitol |
| Q59503277 | Purification of Lactulose from Mixtures with Lactose Using Pressurized Liquid Extraction with Ethanol−Water at Different Temperatures |
| Q56679233 | RELATIONS BETWEEN ROTATORY POWER AND STRUCTURE IN THE SUGAR GROUP. XXVII. SYNTHESIS OF A NEW DISACCHARIDE KETOSE (LACTULOSE) FROM LACTOSE1 |
| Q85803125 | Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed |
| Q51045284 | Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. |
| Q91574341 | Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy |
| Q58287657 | Rapid Determination of Lactulose in Milk Using Seliwanoff's Reaction |
| Q92568721 | Rapid HPLC method for monitoring of lactulose production with a high yield |
| Q67289922 | Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability |
| Q42557473 | Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice |
| Q60290579 | Rapid determination of lactulose in milk by microdialysis and biosensors |
| Q72188062 | Rapid gas-chromatographic assay of lactulose and mannitol for estimating intestinal permeability |
| Q38303615 | Rapid small intestinal permeability assay based on riboflavin and lactulose detected by bis-boronic acid appended benzyl viologens |
| Q92245914 | Ratio of Lactulose to Furosine as Indicator of Quality of Commercial Milks |
| Q36088033 | Recent advances on prebiotic lactulose production. |
| Q42627988 | Reducing effect of calcium in combination with magnesium and lactulose on body fat mass in middle-aged Japanese women |
| Q91645977 | Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements |
| Q43143733 | Regular lactulose use is associated with lower peritonitis rates: an observational study |
| Q70678710 | Relationship between refractive index and dry-substance content for lactulose syrups |
| Q33449179 | Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. |
| Q41954671 | Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit |
| Q72151154 | Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars |
| Q53247056 | Repeated-batch operation for the synthesis of lactulose with β-galactosidase immobilized by aggregation and crosslinking. |
| Q69502689 | Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time |
| Q36053291 | Revealing the combined effects of lactulose and probiotic enterococci on the swine faecal microbiota using 454 pyrosequencing |
| Q35934935 | Review: lactulose or lactitol may improve hepatic encephalopathy but may be less effective than antibiotics |
| Q37327505 | Review: rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy. |
| Q33456102 | Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months |
| Q33465655 | Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy |
| Q102979876 | Role of Lactulose Rhamnose Permeability Test in Assessing Small Bowel Mucosal Damage in Children with Celiac Disease |
| Q35693125 | Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics. |
| Q78487261 | SPECTROPHOTOMETRIC DETERMINATION OF LACTULOSE WITH METHYLAMINE |
| Q50268670 | STUDIES ON THE MECHANISM OF ACTION OF LACTULOSE (BETA-GALACTOSIDE ACTION OF LACTULOSE (BETA-GALACTOSIDO-FRUCTOSE) IN THE INTESTINE |
| Q88781758 | Safe and effective administration of lactulose retention enema in the ED using specialized rectal medication administration catheter |
| Q28256089 | Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients |
| Q47148948 | Scientific Opinion on the substantiation of health claims related to lactulose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 806) and reduction in intestinal transit time (ID 807) pursuant to Article 13(1) of Regulatio... |
| Q84403028 | Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy |
| Q34985317 | Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo |
| Q92817539 | Sensory profile and technological characterization of boneless dry-cured ham with lactulose added as a prebiotic |
| Q61695394 | Severe allergic reaction to lactulose in a child with milk allergy |
| Q44211909 | Short duration exercise increases breath hydrogen excretion after lactulose ingestion: description of a new phenomenon |
| Q69575330 | Short term effect of lactulose therapy in patients with chronic renal failure |
| Q96346106 | Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome |
| Q59111411 | Simultaneous Determination of Lactulose and Lactose in Conserved Milk by HPLC-RID |
| Q77085999 | Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics |
| Q67562996 | Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change |
| Q43519229 | Simultaneous determination of lactulose and mannitol in urine of burn patients by gas-liquid chromatography |
| Q44668741 | Simultaneous gas-chromatographic measurement of rhamnose, lactulose and sucrose and their application in the testing gastrointestinal permeability |
| Q92612015 | Simultaneous hydrolysis of cheese whey and lactulose production catalyzed by β-galactosidase from Kluyveromyces lactis NRRL Y1564 |
| Q70598649 | Simultaneous quantification of mannitol, 3-O-methyl glucose, and lactulose in urine by HPLC with pulsed electrochemical detection, for use in studies of intestinal permeability |
| Q85388372 | Simultaneous synthesis of mixtures of lactulose and galacto-oligosaccharides and their selective fermentation |
| Q47592533 | Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy |
| Q67888857 | Small bowel transit time measured with native lactulose breath hydrogen test |
| Q34410185 | Small intestinal permeability to mannitol and lactulose in the three ethnic groups resident in west Birmingham |
| Q70493470 | Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease |
| Q72116253 | Sodium benzoate and lactulose for the treatment of hepatic encephalopathy |
| Q36195620 | Some instrumental methods applied in food chemistry to characterise lactulose and lactobionic acid |
| Q43844648 | Some observations of the use of lactulose in the treatment of obstipation in geriatric patients |
| Q48924719 | Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy |
| Q49082130 | Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy |
| Q71834442 | Spectrophotometric determination of lactulose |
| Q84013377 | Spirulina enhances the viability of Lactobacillus rhamnosus E/N after freeze-drying in a protective medium of sucrose and lactulose |
| Q87096257 | Stability of oligosaccharides derived from lactulose during the processing of milk and apple juice |
| Q33717298 | Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability |
| Q68253267 | Starch absorption by healthy man evaluated by lactulose hydrogen breath test |
| Q28371990 | Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine |
| Q35815166 | Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose |
| Q34493855 | Studies on breath methane: the effect of ethnic origins and lactulose |
| Q44841729 | Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. |
| Q44217502 | Studies on lactulose formulations for colon-specific drug delivery |
| Q44179060 | Study of lactulose oxidation by periodic acid |
| Q42508815 | Sub chronic toxicity studies of lactulose in rats. |
| Q90388841 | Subtype Classification of Functional Constipation in Child: PEG versus Lactulose |
| Q28331136 | Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy |
| Q89738240 | Sustainable Electroisomerization of Lactose into Lactulose and Comparison with the Chemical Isomerization at Equivalent Solution Alkalinity |
| Q92071162 | Sustainable Valorization of Whey by Electroactivation Technology for In Situ Isomerization of Lactose into Lactulose: Comparison between Electroactivation and Chemical Processes at Equivalent Solution Alkalinity |
| Q47629252 | Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: a realistic hope? |
| Q58040754 | Synbiotics: the impact of potential prebiotics inulin, lactulose and lactobionic acid on the survival and growth of lactobacilli probiotics |
| Q97646072 | Synthesis of Lactulose in Continuous Stirred Tank Reactor With β-Galactosidase of Apergillus oryzae Immobilized in Monofunctional Glyoxyl Agarose Support |
| Q38808198 | Synthesis of Oligosaccharides Derived from Lactulose (OsLu) Using Soluble and Immobilized Aspergillus oryzae β-Galactosidase |
| Q57129425 | Synthesis of galacto-oligosaccharides derived from lactulose by wild-type and mutant β-galactosidase enzymes from Bacillus circulans ATCC 31382 |
| Q61444538 | Synthesis of galacto-oligosaccharides derived from lactulose by wild-type and mutant β-galactosidase enzymes from Bacillus circulans ATCC 31382 |
| Q51017723 | Synthesis of lactulose in batch and repeated-batch operation with immobilized β-galactosidase in different agarose functionalized supports. |
| Q46644920 | Synthesis of oligosaccharides derived from lactulose and pectinex ultra SP-L. |
| Q57279508 | Synthesis of prebiotic galactooligosaccharides from lactose and lactulose by dairy propionibacteria |
| Q38318939 | Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis |
| Q76621997 | THE PRESENCE OF LACTULOSE IN THE URINE OF INFANTS WITH LACTOSURIA |
| Q64128700 | Targeting the Gut Microbiota to Investigate the Mechanism of Lactulose in Negating the Effects of a High-Salt Diet on Hypertension |
| Q72313117 | Tests with a milk formula containing lactulose for the feeding of newborns |
| Q60199021 | The Effect of Lactulose and Lactitol Administration on Fecal Fat Excretion in Patients with Liver Cirrhosis |
| Q52724032 | The Effect of Lactulose on the Faecal Flora of Patients With Hepatic Encephalopathy |
| Q63242408 | The Effect of Lactulose on the Survival of Lactobacillus rhamnosus in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in vivo |
| Q36979345 | The Effect of the Gelatinous Lactulose for Postoperative Bowel Movement in the Patients Undergoing Cesarean Section |
| Q89509548 | The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure |
| Q43934378 | The H2-lactulose breath test in the study of functional colonopathies |
| Q88521531 | The Heyns Rearrangement Revisited: An Exceptionally Simple Two-Step Chemical Synthesis of D-Lactosamine from Lactulose |
| Q46642364 | The Lactulose Breath Test in Irritable Bowel Syndrome: Is It All Hot Air? |
| Q41590437 | The Lactulose Hydrogen Breath Test as a Diagnostic Test for Small-Bowel Bacterial Overgrowth |
| Q88044927 | The North American Consensus on Breath Testing: The Controversial Diagnostic Role of Lactulose in SIBO |
| Q89492627 | The advantage of polyethylene glycol electrolyte solution combined with lactulose in patients with long interval preparation-to-colonoscopy |
| Q47560763 | The association between a positive lactulose methane breath test and rectocele in constipated patients |
| Q33451768 | The characteristics of the positivity to the lactulose breath test in patients with abdominal bloating |
| Q43249285 | The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK. |
| Q28332903 | The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose |
| Q38346364 | The effect of (a) neomycin and lactulose treatment on systemic and portal serum GABA levels in rats and (b) pH changes on [3H] GABA binding to isolated rat hepatocytes |
| Q51327931 | The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability. |
| Q53578739 | The effect of dietary lactulose on experimental large bowel cancer. |
| Q93689956 | The effect of dose and osmolality of lactulose on the oral-caecal transit time determined by the hydrogen breath test and the reproducibility of the test in normal subjects |
| Q50769768 | The effect of ingested lactulose on absorption of L-rhamnose, D-xylose, and 3-O-methyl-D-glucose in subjects with ileostomies. |
| Q63242398 | The effect of lactose derivatives lactulose, lactitol and lactobionic acid on the functional and technological properties of potentially probiotic Lactobacillus strains |
| Q93554842 | The effect of lactulose in prevention of ventilator associated pneumonia (VAP) |
| Q71622895 | The effect of lactulose on DNA damage induced by DMH in the colon of human flora-associated rats |
| Q52091648 | The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy. |
| Q93554968 | The effect of lactulose on tolerance of gastric feeding in long term ICU patients |
| Q41682774 | The effect of lactulose on urea metabolism and nitrogen excretion in cirrhotic patients |
| Q37291959 | The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial |
| Q45891201 | The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system |
| Q28317480 | The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion |
| Q98466000 | The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats |
| Q43251341 | The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study |
| Q73215312 | The effects of sodium deoxycholate, lactulose and glutamine on bacterial translocation in common bile duct ligated rats |
| Q74508070 | The electroanalysis of mannitol, xylose and lactulose at copper electrodes: voltammetric studies and bioanalysis in human urine by means of HPLC with electrochemical detection |
| Q71602272 | The fermentation of lactulose by colonic bacteria |
| Q46189349 | The immunomodulatory effect of lactulose on Enterococcus faecium fed preruminant calves. |
| Q43315083 | The influence of ispaghula husk and lactulose on the in vivo and the in vitro production capacity of short-chain fatty acids in humans |
| Q43431051 | The lactulose breath hydrogen test and small intestinal bacterial overgrowth |
| Q46308126 | The lactulose breath test (LBT): modified, but still a lot of hot air? |
| Q46678858 | The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin |
| Q67914944 | The lactulose challenge. Part 1. On the cholesterol lowering effect of lactulose |
| Q67914946 | The lactulose challenge. Part 2. Importance of regulation of enteric bile acid circulation by lowering pH value for lithogenesis |
| Q54026347 | The lactulose hydrogen breath test as a measure of orocaecal transit time. |
| Q43324679 | The laxative effects of lactulose in normal and constipated subjects |
| Q45150959 | The many effects of lactulose: a rational approach to its therapeutic use. |
| Q43555582 | The mechanism of action of lactulose in portal systemic encephalopathy: colonic bacterial urease activity and bacterial flora in rats |
| Q48830440 | The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon |
| Q67919416 | The menstrual cycle has no effect on gastrointestinal transit time. Evaluation by means of the lactulose H2 breath test |
| Q43888404 | The metabolism of lactulose by the fecal flora |
| Q38300275 | The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment |
| Q71076112 | The role of lactulose in the prevention of bacterial translocation in surgical trauma |
| Q43635098 | The use of lactulose in portal-systemic encephalopathy |
| Q43309350 | The use of lactulose in post-haemorrhoidectomy patients |
| Q67404494 | The use of lactulose syrup for the control of hyperammonemia in Reye's syndrome: report of case |
| Q67843388 | Therapeutic approach in constipation with special reference to lactulose |
| Q69390549 | Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients |
| Q42129404 | Therapeutic effect of vancomycin hydrochloride, a nonabsorbable antibiotic, on intractable (lactulose resistant) chronic hepatic encephalopathy in cirrhotic patients |
| Q44285482 | Therapy of salmonella enteritis with special reference to lactulose (author's transl) |
| Q43571034 | Thermodynamics of hydrolysis of disaccharides. Lactulose, alpha-D-melibiose, palatinose, D-trehalose, D-turanose and 3-o-beta-D-galactopyranosyl-D-arabinose |
| Q42218541 | Thin-layer chromatographic determination of urinary excretion of lactulose, simplified and applied to cystic fibrosis patients. |
| Q38873815 | Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation |
| Q39450187 | Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial |
| Q91483906 | Transcutaneous electrical nerve stimulation of acupuncture points enhances therapeutic effects of oral lactulose solution on opioid-induced constipation |
| Q30919355 | Transformation of lactulose trihydrate into anhydrous lactulose by fluidized bed drying and its characterization |
| Q33420504 | Transitory laxative threshold of trehalose and lactulose in healthy women. |
| Q86525469 | Treatment of Acute Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes |
| Q35003452 | Treatment of chronic constipation with lactulose syrup: results of a double-blind study |
| Q72429516 | Treatment of chronic hepatic coma with lactulose |
| Q71519067 | Treatment of chronic hepatic encephalopathy with lactulose (30 cases) |
| Q45165187 | Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose) |
| Q72346253 | Treatment of chronic porto-systemic encephalopathy with lactulose |
| Q53962044 | Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously. |
| Q79836144 | Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy |
| Q40332192 | Treatment of healthy salmonella carriers with lactulose beta-galactosido-fructose (author's transl) |
| Q24563355 | Treatment of hepatic encephalopathy: it's not lactulose |
| Q33484105 | Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study. |
| Q33575746 | Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion |
| Q35604987 | Urinary mannitol: lactulose excretion ratios and jejunal mucosal structure |
| Q47296785 | Urinary recovery of lactulose compared to D-xylose absorption kinetics in HIV patients with diarrhea and weight loss |
| Q83990819 | Urinary recovery of orally administered chromium 51-labeled EDTA, lactulose, rhamnose, d-xylose, 3-O-methyl-d-glucose, and sucrose in healthy adult male Beagles |
| Q91111799 | Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis |
| Q89969666 | Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives |
| Q50206879 | Use of lactulose (Amivalex) in the treatment of Salmonella excretors |
| Q60288244 | Use of lactulose as prebiotic and its influence on the growth, acidification profile and viable counts of different probiotics in fermented skim milk |
| Q71237354 | Use of lactulose in chronic constipation. (Preliminary report) |
| Q44770660 | Use of lactulose in the treatment of chronic renal failure |
| Q70468100 | Use of lactulose in the treatment of porto-systemic encephalopathy and chronic constipation |
| Q78622262 | Use of lactulose to create a preponderance of Lactobacilli in the intestine of bottle-fed infants |
| Q26860326 | Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review |
| Q42852399 | Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome |
| Q44849698 | Using a simplex centroid to study the effects of pH, temperature and lactulose on the viability of Bifidobacterium animalis subsp. lactis in a model system |
| Q37681281 | Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms |
| Q37236392 | Utility of wireless motility capsule and lactulose breath testing in the evaluation of patients with chronic functional bloating |
| Q42139240 | Validated HPLC-RI Method for the Determination of Lactulose and its Process Related Impurities in Syrup |
| Q37538998 | Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome |
| Q73064989 | Viscosity and density of lactulose solutions |
| Q53468580 | Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer. |
| Q51162012 | Wrong Idea, Good Results (the Lactulose Story) |
| Q73053752 | [A clinical study of the use of a combination of glucomannan with lactulose in the constipation of pregnancy] |
| Q71146147 | [A study of carbohydrate absorption by expiratory hydrogen test (EHT). 1. Studies by ingestion of lactulose and lactose (author's transl)] |
| Q71247230 | [Bifidum-milk and lactulose in the therapy of chronic liver diseases] |
| Q92459796 | [Christmas article: CO2 footprint of lactulose in Scandinavia] |
| Q80013719 | [Clinical efficacy of duphalac in the treatment of functional constipations] |
| Q85912433 | [Clinical observation of prophylactic lactulose for prevention of oral morphine-induced constipation] |
| Q93828024 | [Comparative study of portocaval encephalopathy treatment with lactulose, lactobacilli and antibiotics] |
| Q70271145 | [Comparison of refractometric and ultraviolet detection methods in lactulose assay by high performance liquid chromatography] |
| Q70387777 | [Determination of some components of a lactulose isomer-mixture and syrup] |
| Q74692187 | [Duphalac (lactulose) in the treatment of chronic constipation in children] |
| Q68923611 | [Effect of lactulose on ammonia metabolism during exercise] |
| Q84774528 | [Effect of lactulose on interleukin-18 madiatid multiple orgern function in severe burned rats] |
| Q68650409 | [Effects of lactulose on blood ammonia levels in beagles with end-to-side portacaval shunt] |
| Q70245158 | [Effects of lactulose on intestinal functions in mice and rats] |
| Q85912422 | [Efficacies of lactulose plus live combined Bacillus subtilis and Enterococcus faecium capsules in the treatment of functional constipation: a multicenter, randomized, double blind, controlled trial] |
| Q95525930 | [Efficacy and safety of lactulose on the treatment of puerperal constipation] |
| Q53792576 | [Efficiency and tolerance of lactulose in constipation in pregnant women] |
| Q78885844 | [Excretion ratio of lactulose and mannitol as intestinal permeability index in healthy Chinese volunteers] |
| Q78500079 | [Experimental alteration of fecal flora in healthy adults caused by eugalan capsules, lactose & Petuely's lactulose syrup.] |
| Q71444395 | [Faecal bacterial flora in cirrhotic patients and effects of administration of antibiotics or lactulose (author's transl)] |
| Q95480931 | [Hepatic encephalopathy -- preventative effects of lactulose] |
| Q54195444 | [Hepatic encephalopathy and its therapy with lactulose] |
| Q54324416 | [Influence of lactitol and lactulose on adhesion properties of Bacillus subtilis probiotic strains]. |
| Q92969606 | [Influencing Factors on Lactulose Breath Test Results] |
| Q93654598 | [Ion chromatographic determination of lactulose and epilactose in the presence of lactose and other carbohydrates in milk and milk products] |
| Q70600774 | [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy] |
| Q72834018 | [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use] |
| Q67700197 | [Lactulose and portocaval encephalopathy: value of its administration by rectal route] |
| Q77589839 | [Lactulose and the microecology of the large intestine] |
| Q69807828 | [Lactulose as an accelerating method in the x'rays diagnostics of the small intestine (author's transl)] |
| Q72685516 | [Lactulose fermentation and lactose absorption in Chilean patients with liver cirrhosis: importance for hepatic encephalopathy therapy] |
| Q70952872 | [Lactulose hydrogen breath test in small intestinal bacterial overgrowth] |
| Q68869863 | [Lactulose in the treatment of chronic portosystemic encephalopathies] |
| Q77600402 | [Lactulose mannitol ratio in patients after operation] |
| Q85912426 | [Lactulose plus live binary Bacillus subtilis in the treatment of elders with functional constipation] |
| Q70717964 | [Lactulose therapy for chronic renal failure] |
| Q69375734 | [Lactulose treatment in 80 cirrhotics: basic considerations and results] |
| Q71399437 | [Laxative effect and tolerance of lactulose administrated in one or two intakes in the treatment of chronic idiopathic constipation. Groupe d'Investigateurs O'Ile-de-France (GIIF)] |
| Q72382907 | [Mannitol and lactulose assay in urine by capillary gas chromatography] |
| Q77898917 | [Measurement of urinary content of lactulose and mannitol by gas chromatography as an index of permeability of the gut] |
| Q71594290 | [Mechanism of action of lactulose in the therapy of hepatic coma] |
| Q83747321 | [Micronized lactulose + paraffin (gel) in constipation] |
| Q88205070 | [Milk, Daily products and Bone health.The effect of lactulose on bone health.] |
| Q71843023 | [New medicine Lactulose (Duphalac)] |
| Q95856334 | [Physiological effects, mechanisms of action and application of lactulose] |
| Q70764284 | [Plasma amino acids in patients with liver cirrhosis treated with lactulose] |
| Q69498497 | [Possible therapeutic uses of lactulose other than in porto-systemic encephalopathy] |
| Q54337495 | [Prebiotic properties of lactite and lactulose under creation of synbiotics of bacillus genus bacteria]. |
| Q54125194 | [Study of the laxative effect of Lactitol as opposed to lactulose in an open, randomized comparative study] |
| Q72044599 | [The cariologic aspects of two laxatives--Senna (Fikonsirap) and Duphalac] |
| Q72820230 | [The dilemma in constipation: laxatives or lactulose] |
| Q72203546 | [The lactulose challenge--history and future of a drug] |
| Q54428272 | [Therapeutic efficacy of vancomycin hydrochloride, a nonabsorbable antibiotic, on intractable (lactulose resistant) chronic hepatic encephalopathy in cirrhotic patients]. |
| Q71694029 | [Therapeutic news. I. Crystalline lactulose] |
| Q69486752 | [Treatment of constipation with lactulose in acute and chronic hepatopathy] |
| Q71117316 | [Treatment of hepatic encephalopathy with lactulose] |
| Q68467125 | [Treatment of patients with chronic liver diseases with lactulose and bifidum milk. Principles and problems] |
| Q73475130 | [Use of lactulose in products of children's dietetic and therapeutic nutrition] |
| Q52539866 | [Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)] |
| Q56679234 | Über den Bifidusfaktor Lactulose |
| Q106054650 | maltulose | stereoisomer of | P3364 |
| Q97479031 | LAKTULOSA SANDOZ | has active ingredient | P3781 |
| Q37155 | World Health Organization Model List of Essential Medicines | has part(s) | P527 |
| Q838966 | irritable bowel syndrome | possible treatment | P924 |